
J-104871
CAS No. 191088-19-4
J-104871 ( —— )
产品货号. M33992 CAS No. 191088-19-4
J-104871 (UNII-6137X5QNJF) is a novel farnesyltransferase (FTase) inhibitor that competitively blocks Ras farnesylation in vivo, inhibits Ras processing in activated H-ras-transformed NIH3T3 cells, and suppresses tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥2519 | 有现货 |
![]() ![]() |
5MG | ¥3900 | 有现货 |
![]() ![]() |
10MG | ¥5588 | 有现货 |
![]() ![]() |
25MG | ¥8446 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称J-104871
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述J-104871 (UNII-6137X5QNJF) is a novel farnesyltransferase (FTase) inhibitor that competitively blocks Ras farnesylation in vivo, inhibits Ras processing in activated H-ras-transformed NIH3T3 cells, and suppresses tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.
-
产品描述J-104871 (UNII-6137X5QNJF) is a novel farnesyltransferase (FTase) inhibitor that competitively blocks Ras farnesylation in vivo, inhibits Ras processing in activated H-ras-transformed NIH3T3 cells, and suppresses tumor growth in nude mice transplanted with activated H-ras-transformed NIH3T3 cells.
-
体外实验——
-
体内实验——
-
同义词——
-
通路MAPK/ERK Signaling
-
靶点Ras
-
受体Ras
-
研究领域——
-
适应症——
化学信息
-
CAS Number191088-19-4
-
分子量708.67
-
分子式C38H32N2O12
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC(O)(=O)C1(C(O)=O)O[C@H](C(N([C@@H]([C@H](C/C=C/C2=NC=3C(O2)=CC=CC3)C=4C=C5C(=CC4)OCO5)C)CC6=CC7=C(C=C6)C=CC=C7)=O)[C@H](C(O)=O)O1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
ARS-1323-alkyne
ARS-1323-alkyne 是一种 switch-II pocket (S-IIP) 抑制剂,也是活细胞中 KRASG12C 核苷酸状态的构象特异性化学报告基因。
-
1-(4-methansulfinylp...
该化合物抑制Ras功能,从而抑制细胞的异常生长。
-
BI-3406
BI-3406 是一种口服活性、高效、选择性的 KRAS 和 Son of Sevenless 1 (SOS1) 相互作用抑制剂 (IC50 : 6 nM),具有抗癌活性。